Registry and Fluid Banking of Pancreatic Cystic Lesions

NCT01769534 | Terminated

• 1 other identifier: 2487
• Study Type: observational
• Target: 107
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to follow patients, who have small mucinous cysts in the pancreas, prospectively over a 5-year period.

Conditions

Pancreatic Cysts

Outcome Measures

Primary Outcomes (1)

• To validate the Sendai criteria prospectively in patients with pancreatic cysts.

  up to 1 year

Eligibility Criteria

• Age: 18 Years - 85 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The patients will present to our endoscopy unit for EUS-FNA to work up pancreatic cystic lesion(s).

You may qualify if:

• consented patients between age 18 to 85 who are referred for EUS evaluation of pancreatic cysts.

You may not qualify if:

• Patient unable to give informed consent
• age\<18 or \>85, patients with clinically suspected pseudocysts.

Sponsors & Collaborators

• University of Oklahoma: lead

Study Sites (1)

Endoscopy Centrer at OU Medical Center

Oklahoma City, Oklahoma, 73104, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Pancreatic cyst fluid

MeSH Terms

Conditions

Pancreatic Cyst

Condition Hierarchy (Ancestors)

Cysts; Neoplasms; Pancreatic Diseases; Digestive System Diseases

Study Officials

• John T Maple, M.D.

  University of Oklahoma

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Target Duration: 5 Years
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 14, 2013
• First Posted: January 16, 2013
• Study Start: June 1, 2012
• Primary Completion: July 1, 2016
• Study Completion: July 1, 2016
• Last Updated: December 19, 2017

Record last verified: 2017-12

Locations

US (1)